Robert Carey insider trades

Open-market stock purchases and sales by Robert Carey, Director at Beyond Air, Inc, from SEC Form 4 filings since Mar 5, 2014.

Track record: 3% of 32 scored buys are up 5% or more since purchase, averaging -56%.

Recent trades

DateStockTradeValue
Nov 4, 2025XAIR Beyond Air, IncSold (not open market)$48.6K
Nov 4, 2025XAIR Beyond Air, IncBought (not open market)$8.8K
Nov 4, 2025XAIR Beyond Air, IncSold (not open market)$16.2K
Nov 4, 2025XAIR Beyond Air, IncSold (not open market)$13.5K
Nov 4, 2025XAIR Beyond Air, IncBought (not open market)$2.4K
Nov 4, 2025XAIR Beyond Air, IncSold (not open market)$58.9K
Nov 4, 2025XAIR Beyond Air, IncBought (not open market)$19.5K
Nov 4, 2025XAIR Beyond Air, IncSold (not open market)$21.6K
Nov 4, 2025XAIR Beyond Air, IncBought (not open market)$3.9K
Nov 4, 2025XAIR Beyond Air, IncBought (not open market)$2.9K
Nov 4, 2025XAIR Beyond Air, IncSold (not open market)$540
Nov 4, 2025XAIR Beyond Air, IncBought (not open market)$98
Nov 3, 2025XAIR Beyond Air, IncBought (not open market)$1M
Nov 3, 2025XAIR Beyond Air, IncSold (not open market)$3.8M
Nov 3, 2025XAIR Beyond Air, IncBought (not open market)$964K

Companies traded

  • XAIR Beyond Air, Inc: 40 buys, last Nov 4, 2025
  • SGMO Sangamo Therapeutics, Inc: other filings, last Jun 12, 2025
  • HZNP Horizon Pharma plc: 2 sales, last Mar 23, 2019
  • AITB AIT Therapeutics, Inc: other filings, last Feb 13, 2019
  • ARGS Argos Therapeutics Inc: other filings, last Jan 19, 2017

Get free alerts when Robert Carey files a new trade →